GSK sets up Nucala and Dupixent showdown in COPD
GSK has said new data leads it to believe Nucala will be "highly competitive" with rival biologic Dupixent in COPD - if it gets approved by the FDA.
US is planning $500m project on 'universal vaccines;' WSJ
The US will spend $500m to develop universal vaccines against multiple virus variants, while planned changes to testing rules are raising concerns.
Skin Analytics' dermatology AI backed for NHS use
An AI-powered tool for triaging patients with suspicious skin lesions, developed by Skin Analytics, will be used by the NHS to reduce waiting times.
J&J's 'Swiss army knife' drug gets first FDA approval
Johnson & Johnson has its first regulatory approval for FcRn blocker Imaavy, getting a green light in the US for generalised myasthenia gravis (gMG).
Senior Republican hits out at Trump's research funding cuts
The Republican chair of the Appropriations Committee has slammed the Trump administration for actions that are putting US biomedical research at risk.
Sales & Marketing
Digital
Market Access
Oncology
Patients
R&D
Partner Content
4th In Vivo Cell Engineering & Gene Editing Summit
This forum brings together the brightest minds from biopharma, academia, and regulatory leadership to explore the full translational journey
6th Gene Therapy Analytical Development Summit Europe
Join 24+ expert speakers and over 90 industry stakeholders to unlock analytical strategies that elevate your development programmes,...
13th Tumor Models Summit Boston | July 22-23, 2025 | Boston,...
Improve preclinical tumor models to enhance translational oncology success.
6th RNA Editing Summit | July 29-31, 2025 | Advance RNA Edit...
The 6th RNA Editing Summit returns to Boston this July, bringing together 60+ experts to propel the next generation of RNA editing therapies
TPD & Induced Proximity Pharma Partnering Summit
Join the TPD & Induced Proximity Pharma Partnering Summit to accelerate partnership interest in your protein degradation pipeline or platform